Association of baseline plasma D-dimer and platelets with progression-free survival in patients with stage IV non-small cell lung cancer treated with anti-PD-1 antibody

Boyue Pang, Jing Wang, Jing Wang, Jiali Zhang, Xiubao Ren, Ying Han · 2024

Read Association of baseline plasma D-dimer and platelets with progression-free survival in patients with stage IV non-small cell lung cancer treated with anti-PD-1 antibody by Boyue Pang, Jing Wang, Jing Wang, Jiali Zhang, Xiubao Ren, Ying Han (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11632421.txt.

Description

Boyue Pang and co-authors ask in 2024 whether two routine blood measures, D-dimer and platelets, forecast how stage IV lung cancer patients fare on anti-PD-1 treatment. Both measures reflect clotting activity, which tracks tumor behavior. The patients studied had no driver gene mutations, the group where treatment decisions are hardest.

Records of 150 patients were compared: one hundred received the antibody plus chemotherapy, fifty chemotherapy alone. Baseline D-dimer and platelet levels were tested against progression-free survival and response rates. Cheap, standard blood tests that sort likely responders from non-responders would spare patients futile treatment and help doctors sequence care. The backward-looking design means the signals need forward testing.

Catalog record

CREATORBoyue Pang, Jing Wang, Jing Wang, Jiali Zhang, Xiubao Ren, Ying Han
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11632421

Browse the full library · About the Tower of Babel